Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-07

Clinical Trial Update: Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating integration of iSBIRT for teen substance use into a pediatric network has been withdrawn after Phase 2/3 planning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Children's Hospital | Conditions: Substance Use | Phase 2, Phase 3 | Status: WITHDRAWN